Westbourne Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,725
Closed -$567K 107
2016
Q2
$567K Sell
3,725
-210
-5% -$32.6K 0.51% 56
2016
Q1
$590K Sell
3,935
-125
-3% -$18.6K 0.56% 54
2015
Q4
$659K Sell
4,060
-1,425
-26% -$224K 0.64% 49
2015
Q3
$759K Sell
5,485
-585
-10% -$92.2K 0.76% 43
2015
Q2
$932K Buy
+6,070
New +$972K 0.85% 41

Other funds holding AMGN

Westbourne Investment Advisors's AMGN Position: Q3 2016 in Review

Westbourne Investment Advisors sold out of Amgen (AMGN) in Q3 2016, closing a stake of 3,725 shares — an estimated $567K sold.

Westbourne Investment Advisors first reported a position in AMGN in Q2 2015 and held it in 5 quarters. The position peaked at $932K in Q2 2015. 1,517 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

  • Westbourne Investment Advisors reported no remaining Amgen position as of Q3 2016 after selling out during the quarter.
  • Westbourne Investment Advisors sold 3,725 Amgen shares in Q3 2016, an estimated $567K.
  • Westbourne Investment Advisors first reported a position in Amgen in Q2 2015 and held it in 5 quarters.
  • Westbourne Investment Advisors's Amgen position peaked at $932K in Q2 2015.
  • 1,517 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on Westbourne Investment Advisors's 13F filing for Q3 2016, filed 4 Nov 2016.